Lumibird SA

€23.65As of Sun 8 Nov 2026, 12:00 UTC
EPA:LBIRDHealthcare
Country France
PE (Fwd) •••
TSR 8Y CAGR 6.56%
Div yield 1.58%
ROE 7.04%
Diagnostics & Research
Beta (5Y) 0.99
PE TTM 36.73
TSR TTM 10.75%
Mkt cap €521.9M
ROIC 6.05%
SE Grade™
Value
Quality
Moat
Consensus
Reference
€23
(1.74%)
(77.06%)
Buy 6|12|2|4|3
4Q25
1Q26
2Q26
3Q26
Earnings per share€
0.64
0.62
0.60
0.57
21.32%
9.19%
(0.02%)
(8.69%)
Revenue€M
30.54
30.93
30.73
32.16
13.28%
9.80%
6.58%
5.71%
Peers (US$586.0M)
Cap (US$)
PE
342.4M
—
104.2M
19.41x
54.39M
36.49x
589.6M
93.63x
Capital
TTM
5Y
10Y
Leveragex
2.273
0.146
0.117
EBIT/Intx
1.043
0.060
0.068
Own earn%
31.75
113.92
114.21
Sh yield%
35.99
26.22
26.96
Owners
Insiders/Inst%
14.07
73.18
Short interest%
2.13
SBC / revenue%
2.83
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
12
Op margin range%
10–14
$1 testx
0.0
Incr. ROIC%
3